Abstract
We have reevaluated the antibiotic susceptibilities of group A beta-hemolytic streptococci in view of recent reports of a high prevalence of erythromycin resistance in Japan and of an increase in penicillin treatment failures in the United States. A total of 474 isolates recovered during a 2- to 3-month period in 1980 were tested. All were susceptible by microtiter broth dilution to a penicillin concentration of less than or equal to 0.03 micrograms/ml (minimal inhibitory concentration), and 473 were killed by less than or equal to 0.06 micrograms/ml (minimal inhibitory concentration). Erythromycin minimal inhibitory concentrations showed a bimodal distribution: 95% were less than or equal to 0.06 micrograms/ml, and 5% were greater than or equal to 1 microgram/ml. Of the minimal bactericidal concentrations, 21% were greater than or equal to 1 microgram/ml and 3% were greater than or equal to 16 micrograms/ml. Group A beta-hemolytic streptococci remain susceptible to the inhibitory and bactericidal actions of penicillin, thus providing no in vitro explanation for the bacteriological relapses reported in some clinical studies. Unlike the Japanese experience, only 5% of our isolates were resistant to erythromycin (minimal inhibitory concentration, greater than or equal to 1 microgram/ml); however, 22% were tolerant (ratio of minimal inhibitory/bactericidal concentrations, greater than or equal to 32).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allen J. L., Sprunt K. Discrepancy between minimum inhibitory and minimum bactericidal concentrations of penicillin for group A and group B beta-hemolytic streptococci. J Pediatr. 1978 Jul;93(1):69–71. doi: 10.1016/s0022-3476(78)80603-9. [DOI] [PubMed] [Google Scholar]
- Dixon J. M., Lipinski A. E. Resistance of group A beta-hemolytic streptococci to lincomycin and erythromycin. Antimicrob Agents Chemother. 1972 Apr;1(4):333–339. doi: 10.1128/aac.1.4.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- EICKHOFF T. C., FINLAND M., WILCOX C. IN VITRO SUSCEPTIBILITY OF GROUP A BETA HEMOLYTIC STREPTOCOCCI TO 18 ANTIBIOTICS. Am J Med Sci. 1965 Mar;249:261–268. doi: 10.1097/00000441-196503000-00002. [DOI] [PubMed] [Google Scholar]
- Finland M., Garner C., Wilcox C., Sabath L. D. Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents. Antimicrob Agents Chemother. 1976 Jan;9(1):11–19. doi: 10.1128/aac.9.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GRIFFITH R. S., BLACK H. R. Erythromycin. Pediatr Clin North Am. 1961 Nov;8:1115–1131. doi: 10.1016/s0031-3955(16)31198-1. [DOI] [PubMed] [Google Scholar]
- Howie V. M., Ploussard J. H. Treatment of group A streptococcal pharyngitis in children. Comparison of lincomycin and penicillin G given orally and benzathine penicillin G given intramuscularly. Am J Dis Child. 1971 Jun;121(6):477–480. doi: 10.1001/archpedi.1971.02100170059005. [DOI] [PubMed] [Google Scholar]
- Maruyama S., Yoshioka H., Fujita K., Takimoto M., Satake Y. Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. Am J Dis Child. 1979 Nov;133(11):1143–1145. doi: 10.1001/archpedi.1979.02130110051007. [DOI] [PubMed] [Google Scholar]
- Rabinovitch M., MacKenzie R., Brazeau M., Marks M. I. Treatment of streptococcal pharyngitis. I. Clinical evaluation. Can Med Assoc J. 1973 May 19;108(10):1271–1274. [PMC free article] [PubMed] [Google Scholar]
- Rosenstein B. J., Markowitz M., Goldstein E., Kramer I., O'Mansky B., Seidel H., Sigler A., Tramer A. Factors involved in treatment failures following oral penicillin therapy of streptococcal pharyngitis. J Pediatr. 1968 Oct;73(4):513–520. doi: 10.1016/s0022-3476(68)80266-5. [DOI] [PubMed] [Google Scholar]
- Stillerman M., Isenberg H. D., Facklam R. R. Treatment of pharyngitis associated with group A Streptococcus: comparison of amoxicillin and potassium phenoxymethyl penicillin. J Infect Dis. 1974 Jun;129(0):suppl–suppl:S177. doi: 10.1093/infdis/129.supplement_2.s169. [DOI] [PubMed] [Google Scholar]